lisdexamfetamine dimesylate

Generic: lisdexamfetamine

Labeler: avkare
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name lisdexamfetamine dimesylate
Generic Name lisdexamfetamine
Labeler avkare
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

lisdexamfetamine dimesylate 60 mg/1

Manufacturer
AvKARE

Identifiers & Regulatory

Product NDC 42291-040
Product ID 42291-040_36c401bd-e228-6fbd-e063-6394a90a5f1f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA202830
DEA Schedule cii
Listing Expiration 2026-12-31
Marketing Start 2025-06-04

Pharmacologic Class

Classes
central nervous system stimulant [epc] central nervous system stimulation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 42291040
Hyphenated Format 42291-040

Supplemental Identifiers

RxCUI
854830 854834 854838 854842 854846 854850
UNII
SJT761GEGS

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lisdexamfetamine dimesylate (source: ndc)
Generic Name lisdexamfetamine (source: ndc)
Application Number ANDA202830 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 60 mg/1
source: ndc
Packaging
  • 90 CAPSULE in 1 BOTTLE (42291-040-90)
source: ndc

Packages (1)

42291-040-90 90 CAPSULE in 1 BOTTLE (42291-040-90)

Ingredients (1)

lisdexamfetamine dimesylate (60 mg/1)

Linked Drug Pages (1)

Lisdexamfetamine Dimesylate ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "36c401bd-e228-6fbd-e063-6394a90a5f1f", "openfda": {"unii": ["SJT761GEGS"], "rxcui": ["854830", "854834", "854838", "854842", "854846", "854850"], "spl_set_id": ["36c40404-fe94-6fb7-e063-6394a90a2657"], "manufacturer_name": ["AvKARE"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 CAPSULE in 1 BOTTLE (42291-040-90)", "package_ndc": "42291-040-90", "marketing_start_date": "20250604"}], "brand_name": "Lisdexamfetamine Dimesylate", "product_id": "42291-040_36c401bd-e228-6fbd-e063-6394a90a5f1f", "dosage_form": "CAPSULE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "42291-040", "dea_schedule": "CII", "generic_name": "Lisdexamfetamine", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lisdexamfetamine Dimesylate", "active_ingredients": [{"name": "LISDEXAMFETAMINE DIMESYLATE", "strength": "60 mg/1"}], "application_number": "ANDA202830", "marketing_category": "ANDA", "marketing_start_date": "20250604", "listing_expiration_date": "20261231"}